The biochip market is in the early stages of growth and hence, not only promises potential but also is susceptible to vagaries of market forces. Competition, patent disputes, expertise constraints (in terms of skilled staff, technical know-how) and monetary strength might be a few impediments for firms engaged in this market. A promising industry arises from three aspects – an aging population, third party reimbursement and a growing number of individuals suffering from typical chronic illnesses. Biochips would undoubtedly evolve in terms of physical, technical characteristics, and with focus on miniaturization of assays, they would turn smaller and more powerful with every single generation. The market is characterized by both intense rivalry and equally properly-developed web of alliances.

These and other industry data and trends are presented in “Biochips: A Global Update of Marketplace Trends &amp Opportunities” by BizAcumen, Inc. Our reports are created to be most comprehensive in geographic coverage and vertical marketplace analyses.

Biotechnology Business: Biochips – A Global Update of Market place Trends &amp Opportunities
Company Profile, SWOT and Revenue Analysis!

1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Strategies &amp Reporting Level three

two. Industry OVERVIEW 4
Promising Biochips Promote Biological Study 4
Marketplace Scenario across Merchandise and Regions 4
DNA Chips Lead the Application Front 5
Probable Business Directions five
Biochip Technology Boosts Personalised Medicine 6
Biochip Technology Spreads beyond Pharma Industry 7
Protein Chips to Shape the Future 7
Proteomics “Chip” into Biochip Technology 8
Towards Growing Minaturization 8
European Advancements Set Diagnostic Procedures 8
Competitive Scenario 8
Main Participants 8
Roche and Affymetrix Taste Good results in the Diagnostics Market place 10
Growing Partnerships between Pharma and Biotech Firms 10
Tech Giants Join the Biochip Fray 11

three. Product FACTS 12
A. DNA Chips 12
B. Protein Chips 13
C. Lab Chips 13

four. APPLICATIONS OF BIOCHIPS 13
Biochip Utilizes 14
Biochips and Pharmaceutical Investigation 14
Biochips and Medical Diagnostics 15
Advantages of Biosensor Chip Technology 15
Biochips and Forensics 16
Biochips and Transplantation Screening 16
Biochips and Identity Testing 16
Biochips and Water and Environmental Testing 16
Food Industry 16

five. TRENDS 17
Industry Characteristics 17
New Items and Players to Drive Industry 17
Important Forces Boosting the Business 17

]]>

Market Structure 17
Business Challenges 18
Price Dearness Pauses Biochips Growth 18
Current Approaches to Biochips 19
The Enterprise of Biochips 19
Technological Trends 20
Sensitivity 20
Microfabrication 20
Density 20
Integrated Chips 21
Patent Trends 21
Patent Applications 21

6. Next GENERATION Technologies 22
Microfluidics Employing CD-ROM Technology 22

7. CORPORATE DEVELOPMENTS 23
Affymetrix Acquires USB 23
Illumina Announces Partnership with Genpathway for ChIP
Sequencing Services 23
Affymetrix and Avesthagen Enter into an Agreement 24
Roche NimbleGen and Affymetrix Announce Expansion of License
Agreement 24
GATC Biotech Establishes New Subsidiary 25
Affymetrix Introduces Total Cytogenetic Answer 25
Sigma Launches ChIP Kit 25
US and Czech Scientists to Create Biochips for Detecting Cancer 26
Roche Takes Over NimbleGen 26
GenTel BioSciences Acquires Protein Chip Platform Assets of GSK 27
Advanced Liquid Logic Acquires Nanolytics 27
Applied Microarrays Acquires Pick GE Healthcare’s Assets 27
Affymetrix and Partners Healthcare Extend Collaboration 28
Agencourt, NuGEN and Affymetrix Clinical Services Collaborate 29
Affymetrix Inks Licensing Agreement with Empire Genomics 29
Caliper Enters into a Licensing Agreement with Monogram
Biosciences 30
Affymetrix and IPSOGEN Sign Agreement 30
bioMérieux and NuGEN Enter into Supply and Cross-License
Agreement 31
VWR and CapitalBio Enter into a Distribution Agreement 31
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal 32
Affymetrix Establishes the European Cytogenetic Study
Initiative. 32
Roche Introduces Gene Expression Services and Arrays 32
Affymetrix Unveils Affymetrix GeneChip Command Console Software 33
Affymetrix Introduces GeneChip Mouse and Rat Gene 1. ST Arrays 33
Affymetrix Unveils Genome-Wide Human SNP Array 6. 34
Caliper Life Sciences Launches High Throughput RNA Assay 35
Applied Biosystems Unveils DNA Tools 35
febit Launches Geniom RT Analyzer 35
Austrian Research Center Develops New Biochip Surface 36
Researchers Create Biochips to Get rid of Animal Testing 36

8. Main PLAYERS 37
Affymetrix (US) 37
Applied Biosystems Group (US) 37
Biomerieux (France) 37
Bio-Rad Laboratories, Inc. (US) 37
Caliper Life Sciences, Inc. (US) 37
Cepheid Inc. (US) 38
GE Healthcare Ltd (UK) 38
Takara Bio, Inc. (Japan) 38
Zyomyx (US) 38

9. Industry ANALYTICS 39

10. THE UNITED STATES 43
Biochips Market place Overview 43
Time Saving Biochips – All Set to Grow 43
Multiple Applications of Biochips Drive Sales 43
Biochip Marketplace Faces Challenges 43

11. CANADA 45

12. JAPAN 46
DNA Chip Based on Printing Technologies 46
DNA Chips to Reveal Links Amongst Genes 47
A Leading Japanese Biochip Player – Takara Shuzo 47
ICAN ™ Technology for Big-Scale Production of DNA Fragments 48

13. EUROPE 50

a. France 52

b. Germany 53

c. The United Kingdom 55

d. Rest of Europe 56

14. REST OF Globe 57
China 58
Basic Environment and Commercial Development 58
Biochip Investigation 58
Status of Biochip Industry in China 59
Taiwan 59
Taiwan Pursues Promise of Biochip Sector 59
International Benefit Sought 60

EXHIBITS

Table 1: Market Shares of Biochips Patent Applications in the
Planet – 2003

Table two: Global Biochips Marketplace by Region for the Period
2007-2015 (Sales in US$ Million)

Table three: Percentage Breakdown of Global Biochips Industry by
Region for the Years 2008 &amp 2012

Table four: Global DNA Chips Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table five: Percentage Breakdown of Global DNA Chips Market by
Region for the Years 2008 &amp 2012

Table 6: Global Protein Chips Market place by Region for the Period
2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown of Global Protein Chips Market
by Region for the Years 2008 &amp 2012

Table 8: Global Lab Chips Market place by Region for the Period
2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Global Lab Chips Market place by
Region for the Years 2008 &amp 2012

Table 10: Biochips Market by Segment in the US: 2007-2015
(Sales in US$ Million)

Table 11: Percentage Breakdown of Biochips Market by Segment
in the US for the Years 2008 &amp 2012

Table 12: Biochips Marketplace by Segment in Canada: 2007-2015
(Sales in US$ Million)

Table 13: Percentage Breakdown of Biochips Market place by Segment
in Canada for the Years 2008 &amp 2012

Table 14: Biochips Marketplace by Segment in Japan: 2007-2015
(Sales in US$ Million)

Table 15: Percentage Breakdown of Biochips Market by Segment
in Japan for the Years 2008 &amp 2012

Table 16: Biochips Marketplace by Region in Europe: 2007-2015
(Sales in US$ Million)

Table 17: Percentage Breakdown of Biochips Market place by Region in
Europe for the Years 2008 &amp 2012

Table 18: Biochips Industry by Segment in Europe: 2007-2015
(Sales in US$ Million)

Table 19: Percentage Breakdown of Biochips Industry by Segment
in Europe for the Years 2008 &amp 2012

Table 20: Biochips Market place by Segment in France: 2007-2015
(Sales in US$ Million)

Table 21: Percentage Breakdown of Biochips Market by Segment
in France for the Years 2008 &amp 2012

Table 22: Biochips Industry by Segment in Germany: 2007-2015
(Sales in US$ Million)

Table 23: Percentage Breakdown of Biochips Industry by Segment
in Germany for the Years 2008 &amp 2012

Table 24: Biochips Market by Segment in the UK: 2007-2015
(Sales in US$ Million)

Table 25: Percentage Breakdown of Biochips Market place by Segment
in the UK for the Years 2008 &amp 2012

Table 26: Biochips Market by Segment in Rest of Europe:
2007-2015 (Sales in US$ Million)

Table 27: Percentage Breakdown of Biochips Market place by Segment
in Rest of Europe for the Years 2008 &amp 2012

Table 28: Biochips Marketplace by Segment in Rest of Globe:
2007-2015 (Sales in US$ Million)

Table 29: Percentage Breakdown of Biochips Market by Segment
in Rest of Globe for the Years 2008 &amp 2012